Axon Enterprise, Inc. (NASDAQ:AXON) Position Raised by Argus Investors Counsel Inc.

Argus Investors Counsel Inc. raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,543 shares of the biotechnology company’s stock after purchasing an additional 51 shares during the quarter. Argus Investors Counsel Inc.’s holdings in Axon Enterprise were worth $1,816,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Motley Fool Asset Management LLC boosted its holdings in Axon Enterprise by 238.7% during the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after acquiring an additional 346,838 shares during the period. 1832 Asset Management L.P. acquired a new stake in shares of Axon Enterprise during the first quarter worth approximately $81,630,000. Vanguard Group Inc. increased its holdings in shares of Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after buying an additional 212,401 shares in the last quarter. Swedbank AB bought a new stake in shares of Axon Enterprise during the first quarter valued at approximately $39,923,000. Finally, Vaughan Nelson Investment Management L.P. grew its stake in shares of Axon Enterprise by 53.2% during the second quarter. Vaughan Nelson Investment Management L.P. now owns 157,094 shares of the biotechnology company’s stock valued at $46,223,000 after purchasing an additional 54,526 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Trading Up 1.2 %

Shares of NASDAQ AXON traded up $5.31 during trading hours on Tuesday, hitting $449.29. The company’s stock had a trading volume of 205,906 shares, compared to its average volume of 519,335. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. Axon Enterprise, Inc. has a 12 month low of $199.29 and a 12 month high of $455.17. The stock has a market cap of $33.95 billion, a price-to-earnings ratio of 117.67, a P/E/G ratio of 11.74 and a beta of 0.94. The business has a 50-day simple moving average of $390.23 and a 200-day simple moving average of $332.92.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.18. The firm had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The company’s revenue was up 34.5% on a year-over-year basis. During the same period last year, the company earned $0.80 earnings per share. On average, analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the completion of the transaction, the director now owns 26,259 shares in the company, valued at $11,500,916.82. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the transaction, the director now owns 26,259 shares in the company, valued at approximately $11,500,916.82. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 371,172 shares of company stock worth $137,000,162 over the last three months. 6.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on AXON. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $400.00 to $525.00 and gave the company a “buy” rating in a research note on Tuesday. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. Bank of America began coverage on Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $380.00 price target for the company. Jefferies Financial Group initiated coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective on the stock. Finally, JMP Securities lifted their price target on Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, September 12th. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $375.00.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.